Racial and Ethnic Disparities in Receipt of Guideline-Concordant Pancreatic Cancer Care Among Older Adults in the United States
Rassische und ethnische Unterschiede beim Erhalt leitliniengerechter Pankreaskarzinomversorgung bei älteren Erwachsenen in den USA
JCO Oncology Practice · 2026-06 · 22 (6) · 1075-1086
DOI: 10.1200/op-25-00351 ↗Auf einen Blick
Bei älteren Menschen mit Pankreaskarzinom erhielten 56,3 % eine leitliniengerechte Versorgung. Bei nach NH-Black racialisierten Patient:innen war sie bei Stadium I/II seltener als bei NH-White.
Fragestellung
Unterschieden sich ältere Erwachsene mit Pankreaskarzinom in den USA nach Rasse/Ethnie im Erhalt leitliniengerechter Versorgung?
Methode
Analyse der SEER-Medicare-Datenbank von 2004 bis 2019; Patient:innen ab 65 Jahren mit inzidentem Pankreaskarzinom; multivariable logistische Regression und Oaxaca-Blinder-Zerlegung.
Ergebnisse
12.772 Patient:innen: 10.915 NH-White, 992 NH-Black, 865 hispanisch. GCC insgesamt 56,3 %. NH-Black vs. NH-White: Stadium I/II OR 0,66 (95 %-KI 0,53–0,83), Stadium III OR 0,65 (95 %-KI 0,41–1,01), Stadium IV OR 0,87 (95 %-KI 0,66–1,14).
Schlussfolgerung der Autor:innen
Etwa die Hälfte der versicherten Population mit Pankreaskarzinom erhielt GCC; die Autor:innen sehen Bedarf für besseren multidisziplinären Zugang und Behandlung. Die Black-White-Unterschiede bestanden weiter, besonders bei frühem Stadium.
Kernaussagen
- 56,3 % erhielten leitliniengerechte Versorgung
- NH-Black: seltener GCC bei Stadium I/II als NH-White
- Unerklärte Unterschiede blieben trotz Zerlegung bestehen
Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.
Kurz gefasst
Leitlinie in der Zeitschrift JCO Oncology Practice, 2026-06. Verfasst von Joshua Herb und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX. Hauptthemen laut MEDLINE: Pancreatic Neoplasms, Healthcare Disparities. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, NIA NIH HHS.
Abstract (Originalsprache)
PURPOSE Patients racialized as Black experience a higher mortality from pancreatic cancer (PC). Worse survival outcomes may relate to differences in delivered treatment. This study examined differences in receipt of guideline-concordant care (GCC) among older adults with PC according to race and ethnicity. METHODS Patients 65 years and older with incident PC racialized as non-Hispanic White (NH-White) or racialized as NH-Black or of Hispanic ethnicity were identified in the SEER-Medicare database from 2004 to 2019. The primary outcome was receipt of stage-specific GCC. Multivariable logistic regression identified factors associated with GCC. Oaxaca-Blinder decomposition examined the contribution of measured and unmeasured variables to racial disparities in receipt of GCC. RESULTS Of 12,772 patients included, 85.5% of patients racialized as NH-White (n = 10,915), 7.8% of patients racialized as NH-Black (n = 992), and 6.8% of patients were of Hispanic ethnicity (n = 865). In total, 56.3% of patients received GCC. On adjusted analysis, patients racialized as NH-Black were less likely to receive GCC for stage I/II disease compared with patients racialized as NH-White (odds ratio [OR], 0.66 [95% CI, 0.53 to 0.83]), but not for stage III (OR, 0.65 [95% CI, 0.41 to 1.01]) or stage IV (OR, 0.87 [95% CI, 0.66 to 1.14]). GCC did not differ between Hispanic patients and NH-White patients. On decomposition analysis, differences in GCC among NH-Black and NH-White patients remained largely unexplained, but dual eligibility, census tract–level poverty, and comorbidities were the measured factors that contributed most to the disparity in GCC. CONCLUSION Approximately half of an insured population with PC receives GCC, highlighting a need to improve multidisciplinary access and treatment. Black-White racial disparities in receipt of GCC remain prevalent, particularly for early-stage disease. The unmeasured factors driving treatment disparities warrant prospective studies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX.
- Department of Health Services Research, The University of Texas MD Anderson Cancer Center, Houston, TX.
- Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX.
ORCID-Profile: Joshua Herb, John K Lin, Kever A Lewis, Sharon H Giordano, Matthew H G Katz, Rebecca A Snyder
Förderung
- NCI NIH HHS
- NIA NIH HHS
Zitieren
APA
Herb, J., Liao, K. P., Lin, J. K., Lewis, K. A., Giordano, S. H., Katz, M. H. G., & Snyder, R. A. (2026). Racial and Ethnic Disparities in Receipt of Guideline-Concordant Pancreatic Cancer Care Among Older Adults in the United States. JCO Oncology Practice, 22(6), 1075-1086. https://doi.org/10.1200/op-25-00351
Vancouver
Herb J, Liao KP, Lin JK, Lewis KA, Giordano SH, Katz MHG, et al. Racial and Ethnic Disparities in Receipt of Guideline-Concordant Pancreatic Cancer Care Among Older Adults in the United States. JCO Oncology Practice. 2026;22(6):1075-1086. doi:10.1200/op-25-00351
BibTeX
@article{Herb2026,
author = {Herb, Joshua and Liao, Kai-Ping and Lin, John K and Lewis, Kever A and Giordano, Sharon H and Katz, Matthew H G and Snyder, Rebecca A},
title = {Racial and Ethnic Disparities in Receipt of Guideline-Concordant Pancreatic Cancer Care Among Older Adults in the United States},
journal = {JCO Oncology Practice},
year = {2026},
volume = {22},
number = {6},
pages = {1075--1086},
doi = {10.1200/op-25-00351}
}
EUVIMED